ANALYSIS OF DIRECT MEDICAL COSTS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AT CAI NUOC GENERAL HOSPITAL IN 2022-2023
Main Article Content
Abstract
Background: The study to determine the direct medical costs of treating chronic obstructive pulmonary disease has great practical value. Objectives: Analysis of direct medical costs of treatment in patients with chronic obstructive pulmonary disease at Cai Nuoc General Hospital in 2022-2023. Materials and methods: Patients and medical records of patients with chronic obstructive pulmonary disease coming to Cai Nuoc General Hospital for examination, inpatient and outpatient treatment in 2022-2023. Cross-sectional descriptive study on 191 patients with convenient sampling method. Results: The average direct medical cost of chronic obstructive pulmonary disease for each treatment session of 1 patient was 1.73 million VND (minimum was 0.11 million VND, maximum was 10.59 million VND). In which, drug expenses accounted for the highest proportion (50.22%). The rate covered by health insurance reached 95.7%. Treatment costs in male patients were higher than in female patients (2.01 million VND compared to 0.61 million VND, p<0.001); Inpatient treatment costs were higher than outpatient treatment costs (4.33 million VND compared to 0.48 million VND, p<0.001); Treatment costs increase with the degree of airway obstruction (level 1: 0.76 million VND; level 2: 1.64 million VND; level 3: 2.10 million VND; level 4: 3.74 million VND; p<0.001). Conclusions: The average direct medical cost of chronic obstructive pulmonary disease for each treatment session of 1 patient was 1.73 million VND. Mostly drugs costs. The payment rate of health insurance was very high. Factors that increase the cost of treatment were related to gender, number of years with chronic obstructive pulmonary disease and degree of airway obstruction.
Article Details
Keywords
chronic obstructive pulmonary disease, direct medical costs of treatment, related factors
References
2. Phạm Huy Tuấn Kiệt, Vũ Văn Giáp, Nguyễn Thị Thanh Hà. Chi phí trực tiếp cho y tế trong điều trị bệnh phổi tắc nghẽn mạn tính theo phân loại GOLD dựa trên phân tích dữ liệu lớn từ bảo hiểm y tế Việt Nam năm 2020. Tap chí Y học Việt Nam. 2022, 514(2), 284-288.
3. Võ Thị Thanh Thảo. Phân tích chi phí điều trị bệnh phổi tắc nghẽn mạn tính tại Bệnh viện Đa khoa Đồng Nai giai đoạn 2015 - 2018. Luận văn chuyên khoa cấp II. Đại học Y dược TPHCM. 2018, 95.
4. Huỳnh Văn Thừa. Nghiên cứu đặc điểm lâm sàng, cận lâm sàng, một số yếu tố nguy cơ và kết quả điều trị bệnh nhân đợt cấp bệnh phổi tắc nghẽn mạn tính tại Bệnh viện đa khoa Trung tâm An Giang năm 2018-2019. Luận văn bác sỹ chuyên khoa II. Trường Đại học Y dược Cần Thơ. 2019, 86.
5. Bùi Thị Xuân, Ngô Tiến Thành, Tô Khánh Linh. Phân tích chi phí điều trị trực tiếp đợt cấp bệnh phổi tắc nghẽn mạn tính tại Khoa Hô Hấp - Bệnh viện E từ tháng 10 năm 2019 đến tháng 3 năm 2020. Tạp chí Khoa học Đại học Quốc gia Hà Nội. 2020, 36(2), 84-93.
6. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the Diagnosis, Management, And Prevention of Chronic Obstructive Pulmonary Disease 2022 Report. https://goldcopd.org/2022-gold-reports-2/
7. Wacker M.E., Jorres R.A., Schulz H., et al. Direct and indirect costs of COPD and its comorbidities: Results from the German COSYCONET study. Respir Med. 2016, 111, 39-46.
8. WHO. World Health Statistics 2021. 2021, 1-121.